Tags: bioengineering

Online Presentations (1-20 of 32)

  1. How to Engineer Human Microbiomes?

    02 Mar 2017 | | Contributor(s):: Mohit Verma

    We are developing tools based on nanotechnology, bioengineering, and analytical chemistry to understand causal relationships between microbiomes and their hosts, and to manipulate microbiomes for desirable outcomes, e.g. to shift patients from unhealthy to healthy states. One of these tools uses...

  2. [Illinois] Rare Events with Large-Impact: Bioengineering & Clinical Applications of Circulating Tumor Cells

    04 Feb 2016 | | Contributor(s):: Mehmet Toner

  3. [Illinois] RiPPs: A Treasure Trove for Bioengineering

    04 Feb 2014 | | Contributor(s):: Wilfred A. van der Donk

  4. [Illinois] Stretchy Electronics That Can Dissolve in Your Body

    27 Sep 2013 | | Contributor(s):: John Rogers

    Biology is soft, curvilinear, and transient; modern silicon technology is rigid, planar, and everlasting. Electronic systems that eliminate this profound mismatch in properties will lead to new types of devices, capable of integrating noninvasively with the body, providing function over some...

  5. [Illinois] Genetic Engineering for Nisin Diffusion and Tool Walkthrough

    30 Jul 2013 | | Contributor(s):: Asha Kirchhoff

    In this video Illinois Bioengineering student Asha Kirchhoff discusses the fundamentals behind the Biomedical Engineering Society's Nisin Diffusion experiment and setup for Engineering Open House. She also provides a walkthrough for the Nisin Diffusion tool hosted here at Nanohub.org.

  6. [Illinois] BioNanotechnology Seminar Series Spring 2013: Using Primary Cells for Bioengineering

    14 May 2013 | | Contributor(s):: Mahendra S. Rao

  7. [Illinois] ECE 416 SPR Sensors I

    27 Feb 2013 | | Contributor(s):: Brian Cunningham

               This lecture was an introduction to Surface Plasmon Resonance (SPR) Sensors. It started out with an explanation of Coulomb's Law for the force between two charges. This lead to the concept of the electric field and with an applied...

  8. [Illinois] BioEngineering Seminar Series: Novel Receptor-Targeting Radiolabeled Peptides for Cancer Imaging

    26 Nov 2012 | | Contributor(s):: Yubin Miao

    Gonadotropin-releasing hormone (GnRH) and melanocortin-1 (MC1) receptors are attractive molecular targets for cancer imaging due to their over-expressions on cancer cells. GnRH and alpha-melanocyte stimulating hormone (α-MSH) peptides can bind the GnRH and MC1 receptors with nanomolar...

  9. [Illinois] CABPN Workshop

    26 Nov 2012 | | Contributor(s):: Rashid Bashir, Matthew V. Schulmerich, Jianjun Cheng, Brian Cunningham, William Helferich, Manas Ranjan Gartia, Jozef L. Kokini, Lila Vodkin

    CABPN is a National Science Foundation (NSF) Industry/University Cooperative Research Center. Its mission is to conduct industry-relevant fundamental research, enhance graduate education and research, and to facilitate technology transfer to industry.(Source: http://cabpn.illinois.edu/index.php)

  10. [Illinois] Biophotonics 2011: Intro to Cellular Bioengineering

    15 Jun 2012 | | Contributor(s):: Yingxiao "Peter" Wang

    Biophotonics Summer School 2011The Biophotonics Summer School brings together from a wide variety of disciplines to teach students about the biophotonics field. In 2011, some of the topics covered included principles of biophotonics, technology and methods of investigation. The latest research...

  11. [Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity

    09 May 2012 | | Contributor(s):: David H. Aggen

    To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A high-affinity TCR specific for an antigenic peptide-major histocompatibility complex (pepMHC) can...

  12. [Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies

    09 May 2012 | | Contributor(s):: John A. Katzenellenbogen

    The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however, continues to be challenging. Measurement of estrogen receptor (ER) levels in tumor biopsy samples using...

  13. [Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma

    09 May 2012 | | Contributor(s):: Joseph Brancheck

    Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second most common cancer overall in Caucasians. Due to an aging population and increasing sun exposure, the...

  14. [Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research

    09 May 2012 | | Contributor(s):: Leslie Hammersmith

    Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences, stand up for all people affected by cancer and gain a feeling of control over our own healthcare. Young...

  15. [Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis

    09 May 2012 | | Contributor(s):: Daniel A. Heller

    Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time cancer is detected, metastasis has already occurred. Over 80% of patients diagnosed with lung cancer,...

  16. [Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues

    09 May 2012 | | Contributor(s):: Michael Walsh

    Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for evaluating the presence and severity of most diseases. Current histopathological techniques use of panel of...

  17. [Illinois] Cancer Community Symposium 2012: Panel Discussion

    09 May 2012 | | Contributor(s)::

    Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith (moderator), Jennifer Smith, and Patience Anders from the local Young Survival Coalition, as well as an...

  18. [Illinois] Cancer Community Symposium 2012: Understanding and Targeting Transcription in Hematological Malignancies

    09 May 2012 | | Contributor(s):: Jonathan D. Licht

    Abnormalities in the epigenetic regulation of chromatin structure and function can lead to aberrant gene expression and cancer development. Epigenetic regulators can be affected by chromosomal rearrangement, point mutations, deletions and amplifications in cancer. The result may be changes in...

  19. [Illinois] Cancer Community Symposium 2012: The Inhibitory Effects of the Antifibrotic Drug Halofuginone on Uterine Leiomyoma Smooth Muscle Cells

    09 May 2012 | | Contributor(s):: Faezeh Koohestani

    Uterine leiomyomas are the most prevalent benign tumors of the reproductive tract in women. Available treatments for leiomyomas are limited to surgical procedures or hormonal therapy, which are costly and have significant side effects. In an effort to develop alternative therapeutic strategies,...

  20. [Illinois] Cancer Community Symposium 2012: Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling

    09 May 2012 | | Contributor(s):: Elvira de Mejia

    Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB SignalingLunasin is a promising chemopreventive agent. The objective was to study the effect of lunasin on human colon...